Search Results for: us stem cell

Weekly reads: neural stem cells, CRISPR brain, Vertex, cytoplasm surprise

neural stem cells

Some people consider the brain to be equivalent to a living computer and in that sense it’s too bad that computers don’t have the equal of neural stem cells to help them fix themselves. Is the internet one big neural network-like web? There was a quake in the stem cell internet as CIRM’s main website […]

Weekly reads: neural stem cells, CRISPR brain, Vertex, cytoplasm surprise Read More »

Google ads policy change to allow unproven cell & gene therapy educational material

Google ads policy, stem cell therapies

A planned change to the Google ads policy will allow some ads for unproven cell and gene therapies. This shift, allowing educational ads, was just announced. I have a few concerns about this change that will start in July. Google ads policy and stem cells This move seems to be a refinement of their “ad ban” policy

Google ads policy change to allow unproven cell & gene therapy educational material Read More »

Weekly reads: Vertex hold, new type of cell division in fish, CAR-T

zebrafish cell division

I remember the first time I ever witnessed human cell division first hand and it was really excitement. I was working as a part-time tech in the Lane Lab at UC San Diego School of Medicine. We studied heart disease and grew human umbilical cord endothelial cell cultures. It was striking to see a plate

Weekly reads: Vertex hold, new type of cell division in fish, CAR-T Read More »

End of FDA “grace period” impacted perinatal cell therapy biotechs

knot in umbilical cord, perinatal cell therapy

If there’s one area of biologics where the FDA has been consistently busy lately it’s the perinatal cell therapy space. The agency has made it clear in the last year that allogeneic birth-related cell products are often drugs requiring premarket approval. This has mainly manifested at a practical enforcement level. We’ve seen actions taken in

End of FDA “grace period” impacted perinatal cell therapy biotechs Read More »

Review of Peter Diamandis Fountain Life clinics: more than stem cell hype?

Fountain Life Peter Diamandis featured

Many of you readers know tech guru Peter Diamandis for his great X PRIZE, but he’s also involved in the regenerative medicine world including a new effort called Fountain Life. Teaming up with life coach Tony Robbins and others for Fountain Life raises some red flags for me. What’s in this article Peter Diamandis and

Review of Peter Diamandis Fountain Life clinics: more than stem cell hype? Read More »

Weekly reads: fibroblasts, cancer stem cells, Parkinson’s

fibroblasts stained

It seems like the field of cell biology has mixed feelings about fibroblasts so I’m going to start off there with the recommended reads. But first, check out our stem cell YouTube channel as we are steadily heading toward 500 subscribers and 30,000 views. Please subscribe. I’ve pasted one of our top videos below, which

Weekly reads: fibroblasts, cancer stem cells, Parkinson’s Read More »

Weekly reads: Melton leaves Harvard, Fuji, BBC blunder, stem cell niche, more

Senolytics restore the stem cell niche in the brains of mice. Fatt, et al. Stem Cell Reports 2022.

Sometimes a post here on The Niche (named after the stem cell niche) sparks a debate between expert stem cell researchers and often that gives much more depth to a topic. Such was the case with my post this week on where things stand with stem cell therapy for heart disease. It led to a

Weekly reads: Melton leaves Harvard, Fuji, BBC blunder, stem cell niche, more Read More »

Stem cell therapy for heart disease: what you need to know

stem cell therapy for hearts

How much promise is there today for stem cell therapy for heart disease? Where do things stand with the clinical research? Patients regularly ask me these kinds of questions. The goal of today’s post is to update you on where things stand. What’s in this post Stem Cell Therapy | Clinical Trials | Delivery of

Stem cell therapy for heart disease: what you need to know Read More »